Jin-Ye Fu1, Chen-Ping Zhang2, Zhi-Yuan Zhang3. 1. Department of Oral & Maxillofacial - Head & Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, 639 Zhi Zao Ju Road, Huang Pu District, Shanghai, 200011, People's Republic of China. fujinye_0712@163.com. 2. Department of Oral & Maxillofacial - Head & Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, 639 Zhi Zao Ju Road, Huang Pu District, Shanghai, 200011, People's Republic of China. 3. Department of Oral & Maxillofacial - Head & Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, 639 Zhi Zao Ju Road, Huang Pu District, Shanghai, 200011, People's Republic of China. zhzhy639@163.com.
Abstract
BACKGROUND: Patients with locally advanced oral cavity cancer sometimes stopped treatment after neoadjuvant chemotherapy. There are no guidelines of the management for these patients. Before designing clinical trials, we conducted this study to investigate their characteristics, reasons of dropout, and the follow-up information. METHODS: Medical records were consecutively reviewed of patients with locally advanced oral cavity cancer who underwent neoadjuvant chemotherapy from Jan 2017 to Dec 2019.Variables were compared between patients stopped treating after chemotherapy and completed treatments by student t-test and Chi-square test. Logistic regression model was used to calculate the odd rations of potential predictors of dropout. The dropout patients were followed up for reasons and results of their decision. RESULTS: A total of 171 patients were included with 23 not undergoing surgery after chemotherapy. The odd ratios of age over 65 and single marital status were 3.11 (95%CI: 1.1, 8.7) and 4.935 (95%CI: 1.5, 16.1), respectively, for the dropout. The median survival of patients without surgery was 7.4 months. Believing that chemotherapy would be effective and being afraid of the consequence of surgery were the main reasons of refusing surgery. CONCLUSIONS: The prognosis was poor of these dropout patients. Symptom relief and fear of surgery were the reasons of dropout. Age and marital status affected their decision. Clinical trials are needed to be designed for these patients.
BACKGROUND:Patients with locally advanced oral cavity cancer sometimes stopped treatment after neoadjuvant chemotherapy. There are no guidelines of the management for these patients. Before designing clinical trials, we conducted this study to investigate their characteristics, reasons of dropout, and the follow-up information. METHODS: Medical records were consecutively reviewed of patients with locally advanced oral cavity cancer who underwent neoadjuvant chemotherapy from Jan 2017 to Dec 2019.Variables were compared between patients stopped treating after chemotherapy and completed treatments by student t-test and Chi-square test. Logistic regression model was used to calculate the odd rations of potential predictors of dropout. The dropout patients were followed up for reasons and results of their decision. RESULTS: A total of 171 patients were included with 23 not undergoing surgery after chemotherapy. The odd ratios of age over 65 and single marital status were 3.11 (95%CI: 1.1, 8.7) and 4.935 (95%CI: 1.5, 16.1), respectively, for the dropout. The median survival of patients without surgery was 7.4 months. Believing that chemotherapy would be effective and being afraid of the consequence of surgery were the main reasons of refusing surgery. CONCLUSIONS: The prognosis was poor of these dropout patients. Symptom relief and fear of surgery were the reasons of dropout. Age and marital status affected their decision. Clinical trials are needed to be designed for these patients.
Entities:
Keywords:
Decision making; Drop-out patients; Median survival; Neoadjuvant chemotherapy; Nonsurgical treatment; Oral cancer
Authors: Aaron W Pederson; Joseph K Salama; Mary Ellen Witt; Kerstin M Stenson; Elizabeth A Blair; Everett E Vokes; Daniel J Haraf Journal: Am J Clin Oncol Date: 2011-08 Impact factor: 2.339
Authors: Corey C Foster; James M Melotek; Ryan J Brisson; Tanguy Y Seiwert; Ezra E W Cohen; Kerstin M Stenson; Elizabeth A Blair; Louis Portugal; Zhen Gooi; Nishant Agrawal; Everett E Vokes; Daniel J Haraf Journal: Oral Oncol Date: 2018-03-16 Impact factor: 5.337
Authors: Michael T Spiotto; Gina Jefferson; Barry Wenig; Michael Markiewicz; Ralph R Weichselbaum; Matthew Koshy Journal: JAMA Otolaryngol Head Neck Surg Date: 2017-07-01 Impact factor: 6.223
Authors: Eli D Scher; Paul B Romesser; Christine Chen; Felix Ho; Yen Wuu; Eric J Sherman; Matthew G Fury; Richard J Wong; Sean McBride; Nancy Y Lee; Nadeem Riaz Journal: Oral Oncol Date: 2015-05-07 Impact factor: 5.337
Authors: Jan B Vermorken; Eva Remenar; Carla van Herpen; Thierry Gorlia; Ricard Mesia; Marian Degardin; John S Stewart; Svetislav Jelic; Jan Betka; Joachim H Preiss; Danielle van den Weyngaert; Ahmad Awada; Didier Cupissol; Heinz R Kienzer; Augustin Rey; Isabelle Desaunois; Jacques Bernier; Jean-Louis Lefebvre Journal: N Engl J Med Date: 2007-10-25 Impact factor: 91.245
Authors: Kerstin M Stenson; Rangesh Kunnavakkam; Ezra E W Cohen; Louis D Portugal; Elizabeth Blair; Daniel J Haraf; Joseph Salama; Everett E Vokes Journal: Laryngoscope Date: 2010-01 Impact factor: 3.325
Authors: Ezra E W Cohen; Joshua Baru; Dezheng Huo; Daniel J Haraf; Maureen Crowley; Mary Ellyn Witt; Elizabeth A Blair; Ralph R Weichselbaum; Fred Rosen; Everett E Vokes; Kerstin Stenson Journal: Head Neck Date: 2009-08 Impact factor: 3.147
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: J Inhestern; H Schmalenberg; A Dietz; N Rotter; G Maschmeyer; M Jungehülsing; C Grosse-Thie; T Kuhnt; M Görner; H Sudhoff; C Wittekindt; O Guntinas-Lichius Journal: Ann Oncol Date: 2017-08-01 Impact factor: 32.976